Emotional dysregulation (ED) is an important outcome moderator of Attention-Deficit/Hyperactivity Disorder (ADHD). We previously found that acute administration of methylphenidate age-dependently modulated neural mechanisms underlying ED, i.e., amygdala reactivity, but effects of chronic methylphenidate administration remain unknown. Following randomization to 16 weeks of methylphenidate or placebo treatment, we here report a lasting improvement in ED, depressive and anxiety symptoms in ADHD children, whereas a transient improvement of ED and depressive symptoms occurred in adults, independent of treatment condition. Although depressive and anxiety symptoms at baseline negatively predicted ADHD symptom change in adults, age-dependent effects on amygdala reactivity were absent.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords